semaglutide and prostate cancer Targeting obesity, metabolic syndrome, cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology Emerging mechanisms of enzalutamide resistance
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



























